243 related articles for article (PubMed ID: 21282274)
1. Risk of cerebrovascular adverse events and death in elderly patients with dementia when treated with antipsychotic medications: a literature review of evidence.
Mittal V; Kurup L; Williamson D; Muralee S; Tampi RR
Am J Alzheimers Dis Other Demen; 2011 Feb; 26(1):10-28. PubMed ID: 21282274
[TBL] [Abstract][Full Text] [Related]
2. Treatment of behavioural and psychiatric symptoms in dementia: implications of recent safety warnings.
Bullock R
Curr Med Res Opin; 2005 Jan; 21(1):1-10. PubMed ID: 15881470
[TBL] [Abstract][Full Text] [Related]
3. [Atypical antipsychotics in elderly patients with dementia].
Selbaek G; Engedal K
Tidsskr Nor Laegeforen; 2008 May; 128(9):1060-1. PubMed ID: 18451888
[TBL] [Abstract][Full Text] [Related]
4. Managing Behavioral and Psychological Symptoms of Dementia (BPSD) in the Era of Boxed Warnings.
Tampi RR; Bhattacharya G; Marpuri P
Curr Psychiatry Rep; 2022 Sep; 24(9):431-440. PubMed ID: 35781675
[TBL] [Abstract][Full Text] [Related]
5. A risk-benefit assessment of risperidone for the treatment of behavioural and psychological symptoms in dementia.
Zaudig M
Drug Saf; 2000 Sep; 23(3):183-95. PubMed ID: 11005702
[TBL] [Abstract][Full Text] [Related]
6. Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: a hospital-based, retrospective, cohort study.
Chan MC; Chong CS; Wu AY; Wong KC; Dunn EL; Tang OW; Chan WF
Int J Geriatr Psychiatry; 2010 Apr; 25(4):362-70. PubMed ID: 19650162
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Atypical Antipsychotics for Behavioral and Psychological Symptoms of Dementia Among Community Dwelling Adults.
Trinkley KE; Sturm AM; Porter K; Nahata MC
J Pharm Pract; 2020 Feb; 33(1):7-14. PubMed ID: 29695193
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics for neuropsychiatric symptoms of dementia: malignant or maligned?
Herrmann N; Lanctôt KL
Drug Saf; 2006; 29(10):833-43. PubMed ID: 16970508
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Reported Comparative Effectiveness and Safety of Atypical Antipsychotics in the Treatment of Behavioral and Psychological Symptoms of Dementia: A Network Meta-analysis.
Yunusa I; Alsumali A; Garba AE; Regestein QR; Eguale T
JAMA Netw Open; 2019 Mar; 2(3):e190828. PubMed ID: 30901041
[TBL] [Abstract][Full Text] [Related]
10. Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies.
Trifiró G; Sultana J; Spina E
Drug Saf; 2014 Jul; 37(7):501-20. PubMed ID: 24859163
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic medication and stroke outcome.
Raivio MM; Laurila JV; Strandberg TE; Tilvis RS; Pitkälä KH
Am J Psychiatry; 2005 May; 162(5):1027; author reply 1027-8. PubMed ID: 15863825
[No Abstract] [Full Text] [Related]
13. Halting Antipsychotic Use in Long-Term care (HALT): a single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia.
Jessop T; Harrison F; Cations M; Draper B; Chenoweth L; Hilmer S; Westbury J; Low LF; Heffernan M; Sachdev P; Close J; Blennerhassett J; Marinkovich M; Shell A; Brodaty H
Int Psychogeriatr; 2017 Aug; 29(8):1391-1403. PubMed ID: 28266282
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
15. 'He was like a zombie': off-label prescription of antipsychotic drugs in dementia.
Harding R; Peel E
Med Law Rev; 2013 Mar; 21(2):243-77. PubMed ID: 23047844
[TBL] [Abstract][Full Text] [Related]
16. Risks and benefits of antipsychotic drugs in elderly patients with dementia.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of atypical antipsychotics for behavioral symptoms of dementia among patients residing in long-term care.
Sturm AS; Trinkley KE; Porter K; Nahata MC
Int J Clin Pharm; 2018 Feb; 40(1):135-142. PubMed ID: 29189977
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis.
Maher AR; Maglione M; Bagley S; Suttorp M; Hu JH; Ewing B; Wang Z; Timmer M; Sultzer D; Shekelle PG
JAMA; 2011 Sep; 306(12):1359-69. PubMed ID: 21954480
[TBL] [Abstract][Full Text] [Related]
19. A review of treatment-emergent adverse events during olanzapine clinical trials in elderly patients with dementia.
Kryzhanovskaya LA; Jeste DV; Young CA; Polzer JP; Roddy TE; Jansen JF; Carlson JL; Cavazzoni PA
J Clin Psychiatry; 2006 Jun; 67(6):933-45. PubMed ID: 16848653
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
